The presence of chronic anovulation associated with higher androgen levels correlates with lower insulin sensitivity and higher prevalence of cardiovascular risk factors, such as IR, impaired glucose tolerance (IGT), T2DM, dyslipidemia and metabolic syndrome (MetS). This evidence concerns the gene INS and type 2 diabetes mellitus.